MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/noajnl/vdag251

Медицинская библиотека · Neuro-oncology advances · 2026

Value-based assessment of repeat surgery for recurrent glioma: A real-world quality-adjusted survival analysis.

Qiao Wanyu, Luo Chen, Gan Tian, Wu Shuai, Xie Xian, Wu Jinsong, Duffau Hugues, Zhang Jie, Yao Ye

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Reoperation for recurrent glioma is widely practiced, yet clinical decision-making remains challenging due to substantial trade-offs between survival gain and postoperative functional burden. High-quality real-world evidence integrating survival and quality-of-life outcomes to inform reoperation decisions remains limited.

METHODS

We conducted a retrospective real-world cohort study of 1304 patients with recurrent glioma treated between 2010 and 2018. Propensity score matching was applied to balance baseline characteristics. Survival outcomes, quality-adjusted life years (QALYs), functional status, and prognostic factors associated with reoperation benefit were evaluated.

RESULTS

In the 1:1 propensity-matched cohort (140 reoperation vs 140 non-reoperation), reoperation was associated with a mean gain of 9.6 months in quality-adjusted life years (QALYs) and a 521-day longer overall survival. Postoperative functional status showed short-term improvement. In the glioblastoma subgroup, reoperation was associated with a numerical gain of 3.5 QALY months, although the confidence interval crossed zero, alongside a 218-day gain in overall survival. Predictive models based on preoperative characteristics demonstrated good discrimination in identifying patients likely to derive survival benefit beyond 6 months.

CONCLUSION

This study provides real-world evidence that carefully selected patients with recurrent glioma may derive quality-adjusted survival benefits from reoperation, thereby supporting individualized surgical decision-making. These findings have implications for value-based surgical decision-making in recurrent glioma, particularly in healthcare systems where balancing survival benefit against functional outcomes and resource use is increasingly important.

Для цитирования: Qiao Wanyu, Luo Chen, Gan Tian, Wu Shuai, Xie Xian, Wu Jinsong, Duffau Hugues, Zhang Jie, Yao Ye. Value-based assessment of repeat surgery for recurrent glioma: A real-world quality-adjusted survival analysis.. Neuro-oncology advances. 2026. DOI: 10.1093/noajnl/vdag251.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.